The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Chicago
Study ID
NCT01280825
Status
Recruiting
Apply to this trial

Conditions

  • Autoimmune Disease
  • Blood Coagulation Disorders
  • Heart Diseases
  • Hepatitis C
  • Inflammatory Bowel Diseases
  • Inflammatory Disease
  • Non-Metastatic Neoplasm
  • Patients Undergoing Routine Health Care

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.

Key Dates

Start date
Jan 14, 2011
Status verified
Mar 2026
Primary completion
Nov 14, 2027
Completion
Dec 14, 2027

Study Design

Enrollment
1,200 participants (estimated)

Arms

  • Arm: Adult Patients
    Adults receiving health care at the University of Chicago Medical Center.

Primary Outcome Measure

Feasibility of incorporating pharmacogenomic testing into routine medical care [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Chicago Medical CenterChicagoIllinois60637-

Find similar trials in Chicago, IL

By research site
University of Chicago Medical Center· Chicago, IL

Related Studies